Informational only — Not medical advice. Always consult a licensed healthcare provider.

Community data Updated 23 hours ago

Indications

This Irbesartan + Hydrochlorothiazide tablet is used to treat hypertension in patients for whom a combination of medicines is appropriate.

⚠️ Always consult a registered physician before taking any medicine.

Pharmacology

Irbesartan: Angiotensin II is a potent vasoconstrictor. It forms from angiotensin I in a reaction catalyzed by angiotensin-converting enzyme (ACE, kininase II). It is the principal pressor agent of the RAS, and it also stimulates aldosterone synthesis and secretion by the adrenal cortex, cardiac contraction, renal resorption of sodium, activity of the sympathetic nervous system, and smooth muscle cell growth. Irbesartan blocks the vasoconstrictor and aldosterone-secreting effects of angiotensin II by binding selectively to the AT1 angiotensin II receptor. Many tissues also have an AT2 receptor, but it is not involved in cardiovascular homeostasis.

Irbesartan is a specific competitive antagonist of the AT1 receptor and has no agonist activity. Its affinity for the AT1 receptor is much greater than for the AT2 receptor (more than 8500-fold). Blockade of the AT1 receptor removes the negative feedback of angiotensin II on renin secretion. Plasma renin activity and circulating angiotensin II then rise, but this does not overcome the effects of irbesartan on blood pressure.

Irbesartan does not inhibit ACE or renin, and it does not affect other hormone receptors or ion channels known to be involved in the cardiovascular regulation of blood pressure and sodium homeostasis. Because it does not inhibit ACE, it does not affect the response to bradykinin (whether this has clinical relevance is not known).

Hydrochlorothiazide: Hydrochlorothiazide is a thiazide diuretic. Thiazides act on the renal tubular mechanisms of electrolyte reabsorption and directly increase the excretion of sodium and chloride in approximately equivalent amounts. Indirectly, the diuretic action of hydrochlorothiazide reduces plasma volume. This brings increases in plasma renin activity, increases in aldosterone secretion, increases in urinary potassium loss, and decreases in serum potassium. The renin-aldosterone link is mediated by angiotensin II, so giving an angiotensin II receptor antagonist together with the diuretic tends to reverse the potassium loss associated with these diuretics.

Pregnancy & Breastfeeding

Irbesartan and Hydrochlorothiazide must not be used in pregnancy, because it is contraindicated. When irbesartan is used during the second and third trimesters, it can cause injury and even death of the developing baby. Thiazides appear in human milk. If the doctor decides the medicine is essential, the patient should stop breast feeding.

⚠️ Talk to your doctor before taking any medicine during pregnancy or while breastfeeding.

Dosage Reference

⚠️ Reference ranges from official sources only. Consult your doctor for personalized dosing.

Adults: A patient whose blood pressure isn't controlled well enough by irbesartan or hydrochlorothiazide alone may be switched to Irbesartan + Hydrochlorothiazide taken once daily, which helps keep dose independent side effects down. The recommended doses (irbesartan and hydrochlorothiazide) are 150-12.5 mg (one 150 tablet), 300-12.5 mg (one 300 tablet) and 300-25 mg (two 150 tablets). The biggest added effect is likely to come when a patient moves from a single medicine to 150-12.5 mg (one 150 tablet). Blood pressure takes 2 to 4 weeks to settle after the dose of this tablet is changed. The usual dose of the 150 tablet is one tablet once daily. More than two tablets once daily is not recommended. The maximal antihypertensive effect is reached about 2 to 4 weeks after starting treatment. Use in patients with renal impairment The usual regimens can be followed as long as the patient's creatinine clearance is 30 mL/min. Patients with hepatic impairment No dose adjustment is necessary in patients with hepatic impairment.

Side Effects & Interactions

Side Effects

No side-effect data recorded yet.